IL6/JAK/STAT3信号轴是SMARCB1缺乏的膀癌的治疗漏洞
Chandra Sekhar Amara1, Karthik Reddy Kami Reddy1,2, Yang Yuntao3
1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030, USA.
膀癌中的SMARCB1损失通过激活STAT3通路来促进瘤生长和转移. 用像TTI-101这样的抑制剂向STAT3显示出治疗这些侵略性瘤的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 在各种固体瘤中,SMARCB1损失很普遍,因此需要确定可操作的途径.
- 了解驱动SMARCB1缺乏癌症瘤进展的机制对于开发有效疗法至关重要.
研究的目的:
- 研究SMARCB1缺乏在膀癌进展中的作用.
- 在SMARCB1缺陷的膀瘤中识别和验证可向途径,特别关注STAT3.
主要方法:
- 在体内使用了SMARCB1淘汰 (KO) 细胞系和正管植入模型.
- 分析了染色体的可访问性,IL6/JAK/STAT3信号传递和基因表达特征.
- 在临床前模型中评估了STAT3抑制剂TTI-101的疗效.
主要成果:
- 缺少SMARCB1可以通过增强STAT3信号传递来驱动膀癌的进展和转移.
- SMARCB1的损失增加了STAT3位点上的染色质可访问性.
- 在临床前模型中,TTI-101治疗显著降低了瘤生长.
- 发现了一种新的基因特征,可以预测SMARCB1缺乏.
结论:
- 缺少SMARCB1会影响IL6/JAK/STAT3通路,促进膀癌的生长和转移.
- 抑制STAT3代表了SMARCB1缺乏的膀癌的潜在治疗策略.
- 识别的基因特征可以帮助针对性治疗的患者分层.
更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
相关概念视频
The JAK-STAT Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
